Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Oct-Dec;65(4):386-390.
doi: 10.22336/rjo.2021.76.

A clinical case of recurrent episcleritis as the initial manifestation of granulomatosis with polyangiitis

Affiliations
Case Reports

A clinical case of recurrent episcleritis as the initial manifestation of granulomatosis with polyangiitis

Andra Carmina Ciotoracu et al. Rom J Ophthalmol. 2021 Oct-Dec.

Abstract

Granulomatosis with polyangiitis (GPA) is a type of small-sized blood vessel vasculitis that predominantly affects the upper airways, lungs and kidneys and associates with the presence of anti-neutrophil cytoplasmic antibodies (ANCA). Nevertheless, any organ of the body can be affected by GPA, including the eye. Occasionally, ocular involvement can be the initial manifestation, thus representing an essential clue for the physician in the early diagnosis of the disease. We present the case of a 53-year-old woman in whom recurrent episcleritis was the first sign of a multisystem disease. All further investigations led to the final diagnosis of GPA. The remission induction therapy chosen by the rheumatologist consisted of intravenous cyclophosphamide (CP) and methylprednisolone pulse-therapy, followed by oral glucocorticoids (GC). Based on the favorable clinical and paraclinical evolution, induction therapy was replaced by remission maintenance therapy. Azathioprine (AZA) was initiated and oral GC were continued, with dose tapering. Complete remission of episcleritis was observed. Abbreviations: GPA = granulomatosis with polyangiitis, EGPA = eosinophilic granulomatosis with polyangiitis, MPA = Microscopic polyangiitis, ANCA = Anti-neutrophil cytoplasmic antibodies, c-ANCA = ANCA to proteinase-3, p-ANCA = ANCA to myeloperoxidase, ELISAs = antigen-specific enzyme-linked immunosorbent assays, ENT = ear, nose, throat, CP = cyclophosphamide, NSAIDs = nonsteroidal anti-inflammatory drugs, AZA = azathioprine, GC = glucocorticoids.

Keywords: cyclophosphamide; episcleritis; glucocorticoids; granulomatosis with polyangiitis; kidney biopsy; nasal biopsy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Left eye episcleritis; different stages of evolution under treatment
Fig. 2
Fig. 2
Renal biopsy. A. Renal parenchyma with glomerular mesangial cell proliferation (black arrow). B. Renal parenchyma with global glomerulosclerosis (black arrow)
Fig. 3
Fig. 3
Nasal mucosa. A. Inflammatory cell infiltrate (lymphocytes, neutrophils, histiocytes) of the lamina propria (10x). B. Subepithelial infiltrate of neutrophils and red blood cells (black arrow) – suggestive of vasculitis (40x)
Fig. 4
Fig. 4
c-ANCA titer evolution during patient follow-up

References

    1. Kitching AR, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;71(6) - PubMed
    1. Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): Clinical aspects and treatment. Autoimmunity Reviews. 2014;11(13):1121–1125. - PubMed
    1. Harper SL, et al. Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol. 2001;5(28) - PubMed
    1. Tarabishy AB, et al. Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol. 2010;5(55):429–444. - PubMed
    1. Pérez-Jacoiste Asín MA, et al. Ocular involvement in granulomatosis with polyangiitis: A single-center cohort study on 63 patients. Autoimmunity Reviews. 2019:493–500. - PubMed

Publication types

MeSH terms

Substances